A recent study conducted by researchers in Denmark examined the potential health risks associated with aluminum salts used as adjuvants in non-live vaccines, a practice that has been in place since 1926. The research was prompted after Robert F. Kennedy Jr., Secretary of Health and Human Services, raised concerns about whether these adjuvants could be linked to chronic diseases.
The Danish team utilized a nationwide registry to analyze data from over 1.2 million children who received varying amounts of aluminum through vaccines between 1997 and 2020. The study looked at the relationship between cumulative exposure to aluminum in early childhood and the development of autoimmune, allergic, and neurodevelopmental disorders.
The findings indicated no correlation between aluminum exposure from vaccines during the first two years of life and increased rates of any of 50 different disorders, including autism and asthma. The authors stated, “This nationwide cohort study did not find evidence supporting an increased risk for autoimmune, atopic or allergic, or neurodevelopmental disorders associated with early childhood exposure to aluminum-adsorbed vaccines.”
According to Paul A. Offit, MD, this is the largest and most well-controlled study on the subject so far.
